Hi there,

In the six months since President Trump’s inauguration, we have seen unprecedented attacks on the press. Instead of pushing back, corporate owners of commercial networks are caving in. Because we do not accept any corporate or government funding, we rely on audience members like you to sustain our work. I hope you will donate today to support our independent journalism.Thanks to a group of generous donors, all donations today will be TRIPLED, which means your $15 gift is worth $45. If you believe that freedom of speech and freedom of the press are essential to the functioning of a democratic society, please donate today. Every dollar makes a difference. Thank you so much.

Democracy Now!
Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Moderna Sues Pfizer, Claiming COVID-19 Vaccine Patent Rights

HeadlineAug 30, 2022

Moderna has sued Pfizer, claiming the company illegally used mRNA technology patented by Moderna to develop its COVID-19 vaccine. The two companies have made record profits off the vaccine. Pfizer has projected $32 billion in COVID vaccine sales this year, while Moderna is forecasting at least $19 billion in sales. Tim Bierley of the group Global Justice Now said in response to Moderna’s lawsuit, “It’s grotesque but unsurprising to see pharma fighting among themselves over who has the right to profiteer the most from the pandemic.” Many public health campaigners have argued the vaccines should be publicly owned since billions of dollars in public funding helped develop them.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top